Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950138-05-000172
Filing Date
2005-02-15
Accepted
2005-02-15 16:36:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 /DOCS AND PROJECTS/ROTH STARK/2005 FILINGS/ feb13ga_dorbiopharma-2.txt SC 13G/A 12922
  Complete submission text file 0000950138-05-000172.txt   14395
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 05617596
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 4142411810
ROTH MICHAEL (Filed by) CIK: 0001010207 (see all company filings)

Type: SC 13G/A